Home/Filings/4/0001209191-21-056202
4//SEC Filing

Halkias Theodore 4

Accession 0001209191-21-056202

CIK 0001831097other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 5:19 PM ET

Size

10.5 KB

Accession

0001209191-21-056202

Insider Transaction Report

Form 4
Period: 2021-09-14
Halkias Theodore
Chief Business Officer
Transactions
  • Sale

    Common Stock

    2021-09-14$28.98/sh58,553$1,696,8665,434 total
  • Exercise/Conversion

    Options (Rights to Buy)

    2021-09-1458,5531,741,447 total
    Exercise: $1.00Exp: 2027-04-27Common Stock (58,553 underlying)
  • Exercise/Conversion

    Common Stock

    2021-09-14$1.00/sh+58,553$58,55363,987 total
  • Sale

    Common Stock

    2021-09-14$28.98/sh100,000$2,898,0000 total(indirect: By Trust)
Footnotes (3)
  • [F1]Includes restricted stock units.
  • [F2]These shares of common stock were held in the Halkias Irrevocable Trust.
  • [F3]These options were granted on April 27, 2017, and fully vested on May 15, 2017.

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001855972

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:19 PM ET
Size
10.5 KB